Group 1 - The core point of the article highlights that Noposion's stock experienced significant trading activity on December 24, with a total of 7.051 million shares traded, amounting to 67.1255 million yuan, at a price of 9.52 yuan, which represents an 8.99% discount compared to the closing price of the day [2] - Over the past three months, Noposion has recorded a total of 10 block trades, with a cumulative transaction amount of 119 million yuan [2] - On the same day, Noposion's closing price was 10.46 yuan, reflecting a 1.45% increase, with a turnover rate of 1.70% and a total transaction volume of 138 million yuan, alongside a net inflow of 500,600 yuan in main funds [2] Group 2 - The stock has seen a cumulative decline of 1.23% over the past five days, with a total net outflow of 21.3244 million yuan during this period [2] - The latest margin financing balance for Noposion is 895 million yuan, which has increased by 24.7837 million yuan over the past five days, representing a growth of 2.85% [2] - Noposion was established on September 18, 1999, with a registered capital of 1.00519131 billion yuan [2]

Group 1: Chemical Sector Performance - The chemical raw materials index increased by 1.62%, while the chemical machinery index decreased by 0.96%, the chemical pharmaceuticals index fell by 1.69%, and the pesticide and fertilizer index rose by 4.21% [1] - The top five rising petrochemical products included folic acid up by 20%, battery-grade lithium carbonate up by 11.08%, nitric acid up by 10.43%, sulfur up by 9.95%, and petroleum coke up by 7.23% [1] - The top five declining petrochemical products were liquid chlorine down by 34%, butadiene down by 7.69%, 2,4-D down by 6.09%, trichloroethylene down by 6.00%, and SBS down by 5.90% [1] Group 2: Oil Sector Performance - The oil processing index rose by 1.39%, while the oil extraction index fell by 0.22%, and the oil trading index increased by 3.44% [1] - International crude oil prices continued to decline, with West Texas Intermediate crude oil futures settling at $56.66 per barrel, down 1.36% from December 12, and Brent crude oil futures settling at $60.47 per barrel, down 1.06% from December 12 [1] Group 3: Capital Market Performance of Listed Chemical Companies - The top five rising listed chemical companies included Sulihua Co., Ltd. up by 30.69%, Xinri Hengli up by 27.48%, Reborn Technology up by 23.25%, Ruihua Tai up by 20.93%, and Shenjian Co., Ltd. up by 20.50% [2] - The top five declining listed chemical companies were Huarong Chemical down by 20.01%, Enjie Co., Ltd. down by 18.36%, Weike Technology down by 13.15%, Jinbantai down by 12.83%, and Xingye Co., Ltd. down by 12.63% [2]

Core Viewpoint - Fubon Technology emphasizes its collaboration with Kangxin Bio, a key player in the bio-pesticide and bio-fertilizer sectors, to enhance its global presence in environmentally friendly products and ensure compliance with upcoming regulations [1] Group 1: Company Overview - Kangxin Bio is recognized as the only co-construction enterprise of the "National Bio-Pesticide Engineering Technology Research Center" and is classified as a national high-tech enterprise in the fields of bio-fertilizers and nitrogen-fixing for gramineous plants, as well as bio-pesticides and root-knot nematodes [1] - The company plans to integrate Kangxin Bio's technological reserves and industrial resources to expand its global layout in bio-fertilizers and bio-pesticides [1] Group 2: Strategic Initiatives - Fubon Technology is enhancing its capabilities across the entire chain from "technology research and development to achievement transformation and market application" [1] - The company is proactively preparing for the new pesticide regulations set to be implemented in 2026 by reviewing its existing product lines and ensuring all products meet the "one product, one certificate" qualification requirements before the deadline [1]

Group 1 - The core point of the article is that the actual controller of Nopson (002215.SZ), Lu Boqiang, and his concerted action party reduced their shareholding, triggering a 1% threshold change in equity [1] Group 2 - From December 1 to December 18, 2025, Lu Boqiang and his concerted action party reduced their holdings by 10,052,000 shares, which is 1% of the company's total share capital [1] - After the reduction, the total shares held by Lu Boqiang and his concerted action party decreased from 351,817,039 shares to 341,765,039 shares, representing a drop in ownership from 35% to 34% of the total share capital [1] - The weighted average price of Nopson during the reduction period was 10.914 yuan, resulting in a total reduction amount of approximately 110 million yuan [1] Group 3 - On November 26, 2025, Nopson announced a plan to issue A-shares to specific targets, aiming to raise no more than 1.45 billion yuan, which will be used for the expansion of blueberry bases, the construction of an international research and development center for small berries, and to supplement working capital [2]

Summary of Key Points Core Viewpoint - The actual controller of Shenzhen Noposion Crop Science Co., Ltd. and its concerted actors plan to reduce their shareholding in the company, which will not affect the company's control or governance structure [1][2]. Group 1: Shareholding Changes - As of September 9, 2025, the actual controller and concerted actors held a total of 353,913,939 shares, representing 35.21% of the company's total share capital, and plan to reduce their holdings by up to 30 million shares (2.98% of total shares) within three months [1]. - On December 1 to December 18, 2025, the actual controller and concerted actors reduced their holdings by 10,052,000 shares, which is 1% of the total share capital, bringing their total holdings down to 341,765,039 shares (34% of total shares) [2]. Group 2: Compliance and Impact - The reduction in shareholding will not lead to a change in the company's control and will not significantly impact the company's governance or ongoing operations [2]. - The shareholding reduction complies with relevant laws and regulations, including the Securities Law of the People's Republic of China and the Shenzhen Stock Exchange's rules, ensuring no violations or breaches of commitments [2][3].

Company Research - Microelectrophysiology (688351.SH) is a leading domestic company in cardiac electrophysiology, providing a comprehensive three-dimensional solution with strong technical barriers. The acceleration of domestic substitution and favorable policies are expected to drive significant performance growth. Additionally, the company's layout in pulse ablation and other sectors is anticipated to contribute to future growth potential [4]. - Taihe Co., Ltd. (301665.SZ) possesses global leading technology and production capacity in core products such as Bacillus thuringiensis and 2,4-D. In the first three quarters of 2025, the company's core product prices rebounded, leading to significant performance improvement. The newly registered pesticide, cyhalofop-butyl, is expected to contribute to additional performance. The company is also enhancing its product matrix by leveraging core processes to develop functional chemicals like tetrachloroethylene and m-phenylenediamine [5]. - Geekplus Technology (2590.HK) is recognized as a global leader in AMR warehousing, with expectations for a value reassessment driven by a "data-algorithm flywheel." The company has a solid position in the global market, with continuous commercialization capabilities. Its full-stack technology creates core barriers, leading to industry-leading efficiency. The effectiveness of its global layout is notable, with a profitability inflection point approaching, and it is entering the embodied intelligence sector, opening up long-term growth opportunities [6].

Core Viewpoint - The actual controller of Shenzhen Noposion Agricultural Science Co., Ltd., Lu Boqiang, and his concerted actions have reduced their shareholding, impacting the company's total shareholding structure [3][4]. Group 1: Shareholding Changes - As of December 1 to December 18, 2025, Lu Boqiang and his concerted actions reduced their shareholding by 10,052,000 shares, which is 1% of the company's total share capital [4]. - After the reduction, the total shares held by Lu Boqiang and his concerted actions decreased from 351,817,039 shares to 341,765,039 shares, representing a drop in ownership from 35% to 34% of the total share capital [4]. Group 2: Compliance and Governance - The shareholding change will not lead to a change in the company's control and will not significantly impact the company's governance structure or ongoing operations [4]. - The reduction complies with relevant laws and regulations, including the Securities Law of the People's Republic of China and the Shenzhen Stock Exchange's rules, ensuring no violations or breaches of commitments occurred [4][5].

Core Viewpoint - The company, Nuo Shun (002215.SZ), announced a reduction in shareholding by its actual controller, Mr. Lu Boqiang, and his concerted parties, indicating a significant change in ownership structure [1] Group 1: Shareholding Changes - The actual controller and his concerted parties reduced their shareholding by 10,052,000 shares, which accounts for 1% of the company's total share capital [1] - Following this reduction, the total shares held by Mr. Lu Boqiang and his concerted parties decreased from 351,817,039 shares to 341,765,039 shares [1] - The ownership percentage of Mr. Lu Boqiang and his concerted parties fell from 35% to 34% of the company's total share capital [1]

以Gilboa为基础的小麦杀菌剂产品预计于2027年登陆英国市场，2029年逐步推广至欧洲其他地区。 智通财经APP获悉，2025年12月18日——安道麦股份有限公司(以下简称"公司"，000553.SZ)与巴斯夫宣布达成战略合作协议，围绕安道麦专有的杀菌有效成 分Gilboa(flumetylsulforim，氟磺菌酮)开展联合开发与商业化合作。此次合作将加速创新性病害管理解决方案上市的步伐，助力欧洲各地农民应对抗性困 扰，确保作物正常出产。 根据协议，在安道麦自有的Gilboa系列产品之外，巴斯夫将基于安道麦的Gilboa有效成分开发并上市新型制剂产品。此次合作将安道麦的创新和复配专长与 巴斯夫强大的开发实力及市场渠道相结合，加快农民获得新一代解决方案的进程。双方将独立确定各自的产品概念、定价、销售及市场推广策略。 欧洲市场面临的监管压力日益严峻，现有有效成分渐次淘汰。农民因此迫切需要高效且可靠的新工具来保障作物的健康与产量。Gilboa为谷物杀菌提供了全 新的作用机制，今年上半年杀菌剂抗性行动委员会(FRAC)确认将其归为FRAC第32组(核酸代谢类)。Gilboa具备多样的开发潜力，有望开发出多种广谱 ...

2025年12月18日——安道麦股份有限公司(以下简称"公司"，000553.SZ)与巴斯夫宣布达成战略合作协议，围绕安道麦专有的杀菌有效成分 Gilboa(flumetylsulforim，氟磺菌酮)开展联合开发与商业化合作。此次合作将加速创新性病害管理解决方案上市的步伐，助力欧洲各地农民应对抗性困扰， 确保作物正常出产。 根据协议，在安道麦自有的Gilboa系列产品之外，巴斯夫将基于安道麦的Gilboa有效成分开发并上市新型制剂产品。此次合作将安道麦的创新和复配专长与 巴斯夫强大的开发实力及市场渠道相结合，加快农民获得新一代解决方案的进程。双方将独立确定各自的产品概念、定价、销售及市场推广策略。 欧洲市场面临的监管压力日益严峻，现有有效成分渐次淘汰。农民因此迫切需要高效且可靠的新工具来保障作物的健康与产量。Gilboa为谷物杀菌提供了全 新的作用机制，今年上半年杀菌剂抗性行动委员会(FRAC)确认将其归为FRAC第32组(核酸代谢类)。Gilboa具备多样的开发潜力，有望开发出多种广谱长效 的病害防治方案，为种植者提供产量与质量的双重保护。 安道麦产品线与创新负责人、执行副总裁Florian Wagner ...